FiteBac® Technology can provide a remarkably clean hospital operating room with improved patient surgical outcomes.
The patented science offers durable bactericidal, fungicidal, virucidal protection for almost everything in the operating suite: VCT tiles, walls, ceilings, medical equipment and even filtering the air.
Surgical gloves, gowns, masks, headwear, drapes, and medical vinyl will contain FiteBac Technology affording unsurpassed protection against the transmission of microbes from healthcare workers to patients.
U.S. FDA Medical Device Master File Number: 2174 Subject: K18 QAMS
FiteBac’s capabilities provide patients extraordinary levels of asepsis with protection in the respiratory tubing, blood bags, endotracheal tubes, catheters, sutures, and wound dressings. Surgical preps with FiteBac as a topical drug can deliver a significant reduction in surgical site infections.
Researchers recognize FiteBac’s technology as an advancement in medical care as it substantially reduces healthcare costs while providing healthier patient outcomes.
Hospital Acquired Infections (HAI) Facts
722,000 HAIs in U.S. Acute Care Hospitals Annually
75,000 Patients with HAIs Died During Their Hospitalization
Global Cost of Hospital Acquired Infections is $15.36 Billion Dollars.
Catheter-Associated Urinary Tract Infections (CAUTIs) make up 38.28% share of Global Market